This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified erythematous conditions
L12_ERYTH_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1208 |
4. Check minimum number of eventsNone |
1208 |
5. Include endpointsNone |
1208 |
6. Filter based on genotype QC (FinnGen only) |
1173 |
Control definitions (FinnGen only)
- Control exclude
- L12_URTICARIAERYTHEMA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified erythematous conditions
based on the number of shared cases.
Similar with more cases:
- Other erythematous conditions
- Urticaria and erythema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1173 | 756 | 417 |
| Unadjusted period prevalence (%) | 0.24 | 0.27 | 0.19 |
| Median age at first event (years) | 54.74 | 54.69 | 54.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1208
- Matched controls
- 12080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L53.9
ICD-10 Finland
Erythematous condition, unspecified
904.8
307.7
845
31
L53.8
ICD-10 Finland
Other specified erythematous conditions
238.5
163.5
165
8
69598
ICD-8 Finland
Erythematous condition, Alii definiti
+∞
113.3
107
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
84.4
231
589
L50.9
ICD-10 Finland
Urticaria, unspecified
10.9
65.5
72
70
69599
ICD-8 Finland
Erythematous condition, Other and unspecified
+∞
58.8
56
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
58.1
348
1455
A46
ICD-10 Finland
Erysipelas
3.2
53.7
251
907
E0000UV, ,
ATC
2.4
47.9
608
3591
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.3
38.3
160
534
D07AC01
ATC
betamethasone; topical
2.2
35.9
497
2946
H02AB06
ATC
prednisolone; systemic
2.1
34.7
633
4151
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
33.7
189
744
R06AE07
ATC
cetirizine; oral
2.1
33.6
591
3808
XQ800
NOMESCO Finland
Prick test
3.5
33.3
124
384
R60.0
ICD-10 Finland
Localized oedema
2.7
30.7
191
792
T78.4
ICD-10 Finland
Allergy, unspecified
4.1
28.9
82
210
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.9
27.7
86
235
L50.0
ICD-10 Finland
Allergic urticaria
7.4
26.8
39
54
E000001, ,
ATC
2.2
26.5
283
1486
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
25.4
399
2410
J01DB01
ATC
cefalexin; oral
2.3
25.2
1021
8471
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
23.6
577
4003
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
22.7
464
3035
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
8.2
21.8
29
36
L50.8
ICD-10 Finland
Other urticaria
22.7
21.8
31
14
XQ802
NOMESCO Finland
Epicutan test
3.8
21.6
67
183
H02AB07
ATC
prednisone; oral
2.2
21.5
198
973
J01FF01
ATC
clindamycin; systemic
1.9
20.4
352
2166
D07AB08
ATC
desonide; topical
2.4
20.4
156
707
S29
ICPC
Skin symptom/complaint other
2.0
20.2
255
1412
R06AX27
ATC
desloratadine; oral
1.9
19.8
360
2251
D07AC13
ATC
mometasone; topical
1.8
19.4
367
2318
L04AX01
ATC
azathioprine; systemic
3.4
19.4
72
222
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
18.5
179
894
R50.9
ICD-10 Finland
Fever, unspecified
2.1
18.3
202
1062
A02BC02
ATC
pantoprazole; systemic
1.8
18.3
814
6520
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
17.6
278
1654
R06AE09
ATC
levocetirizine; oral
2.1
17.5
188
977
L50.3
ICD-10 Finland
Dermatographic urticaria
17.2
17.4
27
16
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
17.4
365
2367
R42
ICD-10 Finland
Dizziness and giddiness
1.8
16.9
290
1767
D07AD01
ATC
clobetasol; topical
2.0
16.9
215
1187
L52
ICD-10 Finland
Erythema nodosum
22.2
16.9
24
11
L26
ICD-10 Finland
Exfoliative dermatitis
64.3
16.8
19
*
L17
ICPC
Foot/toe symptom/complaint
1.8
16.6
360
2351
UJF32
NOMESCO Finland
Coloscopy
1.8
16.5
323
2046
D07AA02
ATC
hydrocortisone; topical
2.0
16.3
185
980
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.2
16.2
150
734
Z3231
NOMESCO Finland
Registered nurse
1.8
16.2
341
2204
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
16.2
127
581
R06.0
ICD-10 Finland
Dyspnoea
1.8
16.1
336
2166
D02AE01
ATC
carbamide; topical
2.6
16.0
95
382
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
15.9
147
719
A92
ICPC
Allergy/allergic reaction NOS
3.7
15.7
50
139
R02
ICPC
Shortness of breath/dyspnoea
2.0
15.1
169
889
R51.80
ICD-10 Finland
Headache
1.9
14.7
199
1119
Z71.8
ICD-10 Finland
Other specified counselling
1.7
14.7
372
2520
134
Kela drug reimbursment
General erythroderma
+∞
14.6
14
*
S18
ICPC
Laceration/cut
1.6
14.4
535
3987
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
14.4
148
754
XQ848
NOMESCO Finland
Dermatological photography
3.6
14.3
47
134
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
13.9
77
299
AA1AD
NOMESCO Finland
CT of head and brain
1.7
13.8
319
2105
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
13.7
418
2959
A08
ICPC
Swelling
2.6
13.6
78
308
6959X
ICD-9 Finland
Erythematous conditions, Unspecified erythematous condition
+∞
13.6
13
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
13.5
124
604
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
13.4
227
1368
D01
ICPC
Abdominal pain/cramps general
2.0
13.4
153
810
M79.6
ICD-10 Finland
Pain in limb
1.6
13.4
500
3714
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
13.3
119
574
C01CA24
ATC
epinephrine; parenteral
2.5
13.3
86
360
J01MA02
ATC
ciprofloxacin; systemic
1.6
13.2
449
3256
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
13.2
225
1358
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
13.0
166
913
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
12.9
82
340
S21
ICPC
Skin texture symptom/complaint
1.9
12.8
177
999
N02BE01
ATC
paracetamol; systemic, rectal
1.9
12.7
1054
9442
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
12.7
558
4285
R06AX22
ATC
ebastine; oral
1.8
12.7
208
1240
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
12.6
285
1862
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
12.6
139
727
R03AC02
ATC
salbutamol; inhalant
1.6
12.4
655
5228
S06
ICPC
Rash localized
2.5
12.4
79
328
J01MA12
ATC
levofloxacin; systemic
1.8
12.3
217
1321
U07
ICPC
Urine symptom/complaint other
2.3
12.3
96
438
E000006, ,
ATC
2.3
12.2
92
413
N02AX02
ATC
tramadol; systemic, rectal
1.6
12.1
493
3710
D05BB02
ATC
acitretin; oral
4.0
12.1
34
87
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
12.0
189
1113
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
11.9
128
662
J01DA01
ATC
[U] cefalexin
1.5
11.7
718
5890
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
11.7
144
781
R4110
NOMESCO Finland
Physiotherapy
1.6
11.5
328
2266
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.1
11.5
24
48
Z2221
NOMESCO Finland
Medical doctor
1.6
11.4
324
2235
J02AC01
ATC
fluconazole; systemic
1.5
11.4
462
3461
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
11.3
64
251
J01MA14
ATC
moxifloxacin; systemic
2.1
11.1
112
565
Y0999
ICD-8 Finland
Other specific examinations and investigations
20.2
11.1
16
8
H02AB04
ATC
methylprednisolone; systemic
1.8
11.1
173
1013
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
11.0
264
1744
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
10.9
89
413
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
10.9
263
1740
A01
ICPC
Pain general/multiple sites
2.0
10.7
118
615
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.9
10.7
50
177
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.1
10.7
44
145
N03AX12
ATC
[U] gabapentin; oral
1.7
10.7
200
1237
A02BC05
ATC
esomeprazole; systemic
1.5
10.6
465
3527
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
10.6
208
1302
A07AA02
ATC
nystatin; oral
2.3
10.6
80
360
A07AA09
ATC
vancomycin; oral
5.1
10.5
22
44
E9399
ICD-8 Finland
Complications and failures arising in connection with medical procedures (excluding subsequent adverse effects).
9.3
10.5
21
23
A04
ICPC
Weakness/tiredness general
1.8
10.5
179
1078
N03AX16
ATC
[U] pregabalin
1.6
10.4
271
1825
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.7
10.4
33
92
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
10.4
90
429
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
10.3
118
625
ZXA05
NOMESCO Finland
Left side
1.6
10.3
289
1984
A02BA02
ATC
ranitidine; systemic
1.7
10.2
229
1484
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.1
262
1761
UKC02
NOMESCO Finland
Cystoscopy
1.8
10.1
171
1026
R01AD09
ATC
mometasone; nasal
1.5
10.1
517
4042
J45
ICD-10 Finland
Asthma
1.9
10.0
122
660
Z3226
NOMESCO Finland
Physiotherapist
1.7
10.0
220
1421
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
9.9
221
1430
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.8
469
3608
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
3.4
9.8
34
101
R52.9
ICD-10 Finland
Pain, unspecified
1.9
9.8
121
658
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
9.7
102
523
A28
ICPC
Limited function/disability NOS
1.7
9.7
194
1219
R4120
NOMESCO Finland
Occupational therapy
2.2
9.6
86
415
M25.5
ICD-10 Finland
Pain in joint
1.5
9.6
369
2713
A02BC01
ATC
omeprazole; systemic
1.6
9.6
303
2134
P01BA02
ATC
hydroxychloroquine; oral
2.0
9.5
106
556
D06BX01
ATC
metronidazole; topical
1.9
9.5
133
753
L14
ICPC
Leg/thigh symptom/complaint
2.0
9.5
100
514
C03CA01
ATC
furosemide; systemic
1.5
9.4
327
2349
A02BC03
ATC
lansoprazole; oral
1.5
9.4
329
2368
R07.3
ICD-10 Finland
Other chest pain
1.9
9.4
132
748
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
9.3
47
174
WZC30, ,
SPAT
2.3
9.3
71
321
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
9.2
103
541
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
9.2
217
1425
L71.9
ICD-10 Finland
Rosacea, unspecified
3.2
9.1
36
116
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
9.1
183
1151
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
9.1
109
586
K30
ICD-10 Finland
Functional dyspepsia
1.8
9.0
132
757
C07AB07
ATC
bisoprolol; oral
1.5
9.0
531
4238
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
8.9
107
576
M54.5
ICD-10 Finland
Low back pain
1.5
8.9
404
3064
R03DC03
ATC
montelukast; oral
1.7
8.8
188
1200
S01
ICPC
Pain/tenderness of skin
2.4
8.8
59
252
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.1
8.8
84
416
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
8.8
607
4979
R21
ICPC
Throat symptom/complaint
1.6
8.8
232
1563
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
8.8
85
423
N30.0
ICD-10 Finland
Acute cystitis
1.7
8.8
191
1227
SPAT1260
SPAT
Consultation of another employee
1.7
8.7
195
1260
L28
ICPC
Limited function/disability (L)
1.6
8.7
200
1301
L20.0
ICD-10 Finland
Besnier prurigo
2.1
8.7
87
438
X58
ICD-10 Finland
Exposure to other specified factors
1.7
8.7
158
967
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.3
8.7
32
99
L04AX03
ATC
methotrexate; systemic
1.9
8.6
117
655
D11
ICPC
Diarrhoea
1.8
8.6
136
798
R03BA05
ATC
fluticasone; inhalant
1.6
8.6
212
1404
J01FA06
ATC
roxithromycin; oral
1.5
8.6
449
3492
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
8.6
315
2284
S97
ICPC
Chronic ulcer skin
2.2
8.6
72
339
TQW80
NOMESCO Finland
Local dermatologic skincare
3.2
8.5
33
105
KMAK, ,
NOMESCO Finland
1.4
8.5
563
4571
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.1
8.5
35
116
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
8.5
99
528
L50
ICD-10 Finland
Urticaria
3.9
8.4
24
62
R01AD08
ATC
fluticasone; nasal
1.5
8.4
310
2248
R07.0
ICD-10 Finland
Pain in throat
2.1
8.4
79
389
S76
ICPC
Skin infection other
2.3
8.4
65
296
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
4.5
8.4
20
45
N02AA05
ATC
oxycodone; systemic
1.6
8.4
193
1257
D02AX
ATC
Other emollients and protectives
2.7
8.4
44
167
J01FA10
ATC
azithromycin; systemic
1.4
8.4
643
5360
E000007, ,
ATC
2.2
8.3
69
323
N05BA04
ATC
oxazepam; oral
1.5
8.3
295
2121
E000002, ,
ATC
1.8
8.3
123
708
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
8.2
117
665
N03AX09
ATC
lamotrigine; oral
2.4
8.2
56
241
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
8.2
34
113
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
8.2
100
541
L04AD01
ATC
ciclosporin; systemic
3.6
8.2
26
73
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.1
156
968
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
8.1
296
2140
B01AB05
ATC
enoxaparin; parenteral
1.5
8.1
346
2584
N05BA01
ATC
diazepam; systemic, rectal
1.7
8.1
150
923
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
8.0
142
861
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
8.0
144
878
D06
ICPC
Abdominal pain localized other
1.9
8.0
97
524
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.9
222
1514
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
7.9
88
461
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.9
450
3543
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.9
268
1907
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.3
7.9
61
278
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.9
145
890
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
7.8
231
1593
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.8
483
3856
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
7.8
28
85
T78.3
ICD-10 Finland
Angioneurotic oedema
4.2
7.8
20
48
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
7.7
175
1133
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
7.7
86
452
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
7.6
145
898
R74
ICPC
Upper respiratory infection acute
1.5
7.6
343
2583
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
2.5
7.6
48
200
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.6
7.6
43
170
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.5
7.6
25
72
P29
ICPC
Psychological sympt/compl other
2.0
7.6
80
412
XX9XE
NOMESCO Finland
Other ultrasound examination
6.2
7.6
19
31
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
7.5
73
364
A69.2
ICD-10 Finland
Lyme disease
2.1
7.5
69
337
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
7.5
78
399
N03AE01
ATC
clonazepam; systemic
2.1
7.5
66
317
ZZA00
NOMESCO Finland
Split skin graft
2.8
7.5
37
136
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
7.5
196
1315
S08
ICPC
Skin colour change
2.2
7.5
65
311
N05BB01
ATC
hydroxyzine; systemic
2.1
7.4
73
366
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
2.7
7.4
40
154
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
7.4
51
221
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
7.4
340
2567
M79.3
ICD-10 Finland
Panniculitis, unspecified
13.5
7.4
12
9
R01AD58
ATC
fluticasone, combinations; nasal
1.5
7.3
258
1847
U02
ICPC
Urinary frequency/urgency
1.6
7.3
162
1043
69590
ICD-8 Finland
Erythematous condition, Erythema chronicum migrans
+∞
7.3
7
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
7.3
322
2414
N03AG01
ATC
valproic acid; systemic, rectal
2.1
7.2
70
349
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.2
62
295
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
7.2
304
2256
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.4
7.2
47
199
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
7.2
104
595
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.2
282
2064
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.6
7.2
39
151
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.3
7.1
51
225
L11
ICPC
Wrist symptom/complaint
1.8
7.1
102
582
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.1
7.1
19
47
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.1
245
1747
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.6
7.1
40
158
J05AB11
ATC
valaciclovir; oral
1.6
7.1
161
1044
J01AA02
ATC
doxycycline; systemic
1.4
7.1
869
7753
D07XC01
ATC
betamethasone; topical
1.7
7.1
127
774
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
7.0
80
423
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.0
139
870
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
7.0
79
417
R5110, ,
SPAT
2.0
7.0
78
410
C10AC01
ATC
colestyramine; oral
2.7
7.0
35
130
R03AC03
ATC
terbutaline; inhalant
1.6
7.0
154
991
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
6.9
109
639
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.7
6.9
37
142
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.0
6.9
30
103
L04AA06
ATC
mycophenolic acid; systemic
3.3
6.9
25
77
R03BA01
ATC
beclometasone; inhalant
1.6
6.9
152
979
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.8
62
302
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
6.8
120
727
R04
ICPC
Breathing problem other
2.4
6.8
46
198
R05
ICPC
Cough
1.5
6.8
269
1970
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
6.8
76
400
XLD00, ,
SPAT
4.3
6.8
17
40
N06AX21
ATC
duloxetine; oral
1.7
6.7
132
823
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
6.7
79
423
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
6.7
79
424
A07EA06
ATC
budesonide; oral, local oral
2.4
6.6
45
194
C08CA05
ATC
nifedipine; systemic
2.0
6.6
67
340
T14.0
ICD-10 Finland
Superficial injury of unspecified body region
3.6
6.6
21
59
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
6.6
58
279
A03
ICPC
Fever
1.6
6.6
177
1194
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.6
71
369
N48.1
ICD-10 Finland
Balanoposthitis
3.0
6.6
28
95
ZXA10
NOMESCO Finland
Bilateral
1.5
6.5
203
1413
JN4BD
NOMESCO Finland
Extensive body CT
1.7
6.5
110
658
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.5
196
1355
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.6
6.5
35
135
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
6.5
101
591
N06AX11
ATC
mirtazapine; oral
1.4
6.5
365
2849
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.9
6.5
76
407
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
4.0
6.4
18
46
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
6.4
33
124
TAB00
NOMESCO Finland
Lumbar puncture
2.2
6.4
54
255
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.4
430
3452
R33
ICD-10 Finland
Retention of urine
1.9
6.4
78
422
L30.3
ICD-10 Finland
Infective dermatitis
2.4
6.4
41
172
G50.1
ICD-10 Finland
Atypical facial pain
3.0
6.4
27
91
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
6.4
155
1020
M10.9
ICD-10 Finland
Gout, unspecified
2.0
6.4
68
352
N06AB10
ATC
escitalopram; oral
1.5
6.4
218
1549
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.4
572
4811
L50.1
ICD-10 Finland
Idiopathic urticaria
11.1
6.3
11
10
N05CF01
ATC
zopiclone; oral
1.4
6.3
343
2660
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
6.3
108
651
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
6.3
40
168
L01BA01
ATC
methotrexate; systemic
2.3
6.3
44
193
6958X
ICD-9 Finland
Erythematous conditions, Other specified erythematous conditions[CASUS ERYTHEMATODES ALIA DEFINITA]
+∞
6.3
6
*
R03BA08
ATC
ciclesonide; inhalant
1.8
6.3
97
567
L30.0
ICD-10 Finland
Nummular dermatitis
2.3
6.2
43
187
JAH01
NOMESCO Finland
Laparoscopy
2.2
6.2
49
226
M03BX02
ATC
tizanidine; oral
1.4
6.2
673
5817
SPAT1263
SPAT
Sampling
1.4
6.2
448
3637
F02
ICPC
Red eye
2.2
6.2
52
246
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.2
449
3648
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
6.2
792
7023
R19.4
ICD-10 Finland
Change in bowel habit
2.6
6.2
33
127
HA1AA
NOMESCO Finland
X-ray mammography
1.8
6.1
96
563
E000003, ,
ATC
2.2
6.1
50
234
L04AA01
ATC
[U] ciclosporin
3.8
6.1
18
48
R11
ICD-10 Finland
Nausea and vomiting
1.8
6.1
98
579
E66.8
ICD-10 Finland
Other obesity
2.0
6.1
60
302
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.1
474
3891
N06AB03
ATC
fluoxetine; oral
1.6
6.1
138
894
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
6.1
83
467
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.3
6.1
42
183
L15
ICPC
Knee symptom/complaint
1.4
6.0
263
1957
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.0
111
681
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.0
790
7014
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.0
65
338
A11
ICPC
Chest pain NOS
1.8
6.0
91
528
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
706
4778
2.15
36.14
9.5
6.0
28.36
28.15
%
0.19
672
4484
697
4707
2.14
35.72
9.3
5.8
56.49
56.95
%
0.45
662
4416
106
293
3.87
33.72
2.0
1.5
1.23
1.18
g/l
0.98
101
276
103
280
3.93
33.55
2.0
1.6
0.24
0.24
g/l
0.09
98
267
795
5765
2.11
32.23
12.6
9.0
4.06
4.05
e9/l
0.02
706
5051
167
640
2.87
31.24
2.6
2.4
23.17
24.00
au/ml
0.03
11
43
155
577
2.93
30.55
1.4
1.3
23.60
45.97
au/ml
—
6
41
690
4889
1.96
28.13
8.8
6.7
1.22
1.22
mmol/l
0.13
619
4169
608
4224
1.88
25.31
6.2
4.7
35.42
35.56
g/l
0.23
577
3940
944
7612
2.10
24.79
10.7
7.3
79.61
78.66
u/l
0.28
907
7142
212
1017
2.32
24.57
4.3
4.2
242.66
251.73
u/l
0.33
201
964
106
367
3.07
23.61
1.4
1.2
0.22
1.16
u/ml
—
9
28
624
4445
1.84
23.29
8.0
6.0
1.21
1.22
mmol/l
0.76
595
4038
911
7318
2.00
23.23
5.8
4.0
12.64
12.26
mm/h
0.32
868
6758
685
5079
1.81
21.83
7.9
6.2
11.26
11.17
umol/l
0.06
658
4813
153
682
2.42
20.78
1.9
1.6
—
—
—
0
0
441
2904
1.82
20.61
2.6
2.1
206.06
238.52
u/l
0.18
427
2740
470
3210
1.76
19.05
4.7
3.1
30.46
32.58
u/l
0.67
451
3048
817
6517
1.78
19.00
6.2
4.4
11892.00
3032.27
e6/l
—
5
90
225
1223
2.03
18.62
2.8
2.3
97.36
120.55
ug/g
0.85
184
976
158
754
2.26
18.26
3.0
2.9
10.41
10.50
g/l
0.08
149
690
645
4849
1.71
18.21
4.9
3.7
0.00
0.00
estimate
0.50
120
967
490
3437
1.72
17.72
5.1
3.6
104.34
88.07
e6/l
0.12
350
2425
649
4909
1.70
17.72
5.0
3.7
0.03
0.00
estimate
0.41
110
876
345
2192
1.80
17.64
2.4
1.8
1.47
1.16
mg/l
0.70
260
1673
643
4857
1.69
17.60
6.7
5.0
0.00
0.00
estimate
0.50
113
908
444
3056
1.72
17.04
3.2
2.4
54.35
59.96
u/l
1.52
415
2816
178
916
2.11
16.98
2.3
2.0
342.58
376.80
nmol/l
1.57
168
840
273
1646
1.85
16.41
3.3
2.7
1.07
1.16
e6/l
0.20
156
926
399
2692
1.72
16.32
4.2
3.0
0.25
0.45
e6/l
2.10
307
2052
427
2935
1.70
16.31
4.2
3.1
43.36
79.84
e6/l
0.71
330
2263
369
2437
1.74
16.29
3.1
2.7
2269.63
6572.18
umol/l
1.87
320
2129
371
2478
1.72
15.61
6.0
3.9
91.04
91.79
%
0.21
362
2410
81
304
2.78
15.57
2.2
1.8
—
—
—
0
0
538
3974
1.64
15.31
2.3
2.0
94.20
96.00
pmol/l
0.40
288
2021
277
1724
1.79
14.84
1.3
1.2
20.45
30.34
iu/ml
1.12
83
560
253
1543
1.81
14.47
3.5
2.9
3.85
2.79
e6/l
0.66
134
832
1096
9872
2.19
14.29
23.9
13.7
21.19
23.31
mg/l
1.59
949
7746
69
250
2.87
14.16
1.4
1.2
2.50
2.58
u/ml
—
6
29
255
1569
1.79
14.13
2.0
1.8
—
—
—
0
0
711
5696
1.60
13.98
6.5
4.7
6.54
6.69
mmol/l
1.29
681
5309
470
3414
1.62
13.95
3.9
3.4
2.36
2.36
mmol/l
0.05
424
2999
69
254
2.82
13.76
1.4
1.2
27.84
8.41
u/ml
—
9
47
549
4153
1.59
13.66
2.9
2.3
75.80
77.57
nmol/l
0.81
516
3715
357
2432
1.66
13.63
2.9
2.1
2.79
3.00
mg/l
0.93
314
2057
578
4428
1.59
13.61
19.0
14.2
1.27
1.24
inr
0.28
163
1260
564
4297
1.59
13.59
3.7
2.7
124.84
118.42
ug/l
0.24
529
3950
242
1484
1.79
13.50
2.9
2.1
29.97
29.60
s
0.39
235
1438
123
599
2.17
13.43
1.7
1.7
1.20
1.45
g/l
0.89
112
554
287
1854
1.72
13.33
4.6
3.7
245.83
343.32
ng/l
0.35
220
1429
167
920
1.95
13.04
2.5
2.1
0.22
0.21
g/l
0.20
160
863
58
203
2.95
12.68
1.4
1.2
57.13
40.28
u/ml
—
8
18
190
1104
1.86
12.59
4.2
2.9
9.25
7.71
umol/l
0.42
160
957
217
1315
1.79
12.53
7.4
5.3
1.04
1.05
mmol/l
0.10
204
1207
189
1108
1.84
12.15
1.8
1.8
—
—
—
0
0
187
1097
1.83
11.99
1.8
1.8
—
—
—
0
0
901
7772
1.63
11.91
4.9
4.0
14.85
14.79
pmol/l
0.35
846
7073
119
600
2.09
11.87
1.3
1.2
410.13
227.02
u/ml
0.60
106
547
295
1981
1.65
11.64
1.6
1.5
2.20
2.39
g/l
1.02
186
1216
756
6297
1.54
11.32
3.4
3.0
—
—
—
0
0
767
6428
1.53
11.00
4.4
3.1
49.18
46.61
u/l
0.34
723
5978
142
783
1.92
11.00
2.6
2.8
66.84
66.64
g/l
0.11
136
717
478
3648
1.51
10.62
4.6
3.5
40.31
43.61
ng/l
0.07
331
2490
230
1485
1.68
10.46
2.9
2.4
12.83
13.00
umol/l
0.14
215
1380
77
344
2.32
10.34
2.5
2.4
2.85
2.97
g/l
0.50
71
310
72
313
2.38
10.29
2.4
2.6
1.21
0.99
g/l
0.14
64
277
214
1361
1.70
10.28
2.8
2.4
2.38
2.33
g/l
0.63
199
1262
1022
9214
1.71
10.17
6.0
4.8
1.83
2.04
mu/l
0.94
967
8433
29
75
3.94
10.16
1.3
1.2
—
—
—
0
0
29
75
3.94
10.16
1.3
1.2
—
—
—
0
0
239
1571
1.65
10.11
4.9
3.4
0.80
0.82
mmol/l
1.22
220
1473
66
278
2.45
10.11
2.5
2.4
0.16
0.02
g/l
0.54
61
258
29
76
3.89
9.98
1.3
1.2
—
—
—
0
0
29
76
3.89
9.98
1.3
1.2
—
—
—
0
0
29
76
3.89
9.98
1.3
1.2
—
—
—
0
0
79
364
2.25
9.88
2.5
2.3
3.45
3.62
g/l
0.54
73
331
79
365
2.25
9.82
2.5
2.3
7.14
7.41
g/l
0.80
73
331
79
365
2.25
9.82
2.5
2.3
—
—
—
0
0
201
1275
1.69
9.72
3.0
2.4
21.88
22.92
%
0.49
165
1082
292
2035
1.57
9.66
3.3
2.4
3.77
6.48
e6/l
4.60
266
1840
373
2750
1.52
9.54
3.3
3.0
1478.04
1226.00
ng/l
0.67
324
2332
304
2144
1.56
9.53
4.8
4.0
1.01
1.02
kg/l
0.96
73
325
71
319
2.30
9.43
2.0
1.6
—
—
—
0
0
171
1046
1.74
9.42
2.8
2.8
1.81
1.83
%
0.08
155
927
67
294
2.35
9.39
3.7
2.8
186.11
185.71
%
0.01
61
282
1097
10162
1.87
9.03
25.1
15.8
139.51
139.65
mmol/l
1.14
1082
9889
242
1639
1.60
8.98
1.3
1.2
10.73
12.63
u/ml
0.16
83
634
67
301
2.30
8.91
1.5
1.5
0.73
0.07
iu/ml
0.43
14
63
152
916
1.75
8.81
2.6
2.2
38.36
34.78
u/l
0.24
137
772
260
1804
1.56
8.67
1.8
1.7
1089.29
1179.02
nmol/l
1.08
210
1354
566
4592
1.44
8.65
3.4
2.6
—
—
—
0
0
135
790
1.80
8.64
2.2
3.0
176.95
191.09
ng/l
0.17
126
727
1097
10189
1.83
8.56
25.5
15.9
3.95
3.96
mmol/l
0.59
1081
9896
60
262
2.36
8.52
2.4
2.4
0.00
0.00
g/l
-0.00
55
244
60
264
2.34
8.38
2.4
2.4
0.00
0.00
g/l
-0.00
55
245
81
407
2.06
8.17
1.8
2.0
1.36
1.52
g/l
0.94
71
356
86
443
2.01
8.11
1.6
2.0
37.08
39.04
u/l
0.46
79
391
312
2291
1.49
7.90
1.7
1.5
20.52
21.23
nmol/l
0.38
277
1931
149
921
1.70
7.87
6.8
3.9
1.52
1.96
mmol/l
0.78
136
750
26
75
3.52
7.84
1.3
1.1
350.00
80.00
titre
—
9
12
307
2251
1.49
7.82
1.4
1.3
1.59
1.54
u/ml
0.03
76
591
21
53
4.01
7.63
1.0
1.1
—
—
—
0
0
250
1769
1.52
7.53
1.7
1.5
—
—
—
0
0
62
290
2.20
7.53
1.2
1.1
—
—
—
0
0
23
63
3.70
7.48
2.3
2.8
—
—
—
0
0
69
341
2.09
7.30
2.5
2.4
11.45
10.31
g/l
0.98
63
306
48
204
2.41
7.27
1.4
1.4
—
—
—
0
0
48
204
2.41
7.27
1.4
1.4
—
—
—
0
0
1117
10512
1.83
7.21
15.5
10.2
25.89
25.53
u/l
0.30
1096
10138
61
289
2.17
7.19
1.2
1.1
—
—
—
0
0
465
3735
1.40
7.09
5.3
3.8
—
—
—
0
0
134
831
1.69
6.99
8.3
7.2
9.24
9.34
mmol/l
0.06
127
794
61
293
2.14
6.95
2.4
2.3
38.33
37.94
g/l
0.23
55
259
61
294
2.13
6.89
1.4
1.4
297.23
289.09
ug/g
0.11
37
172
37
143
2.64
6.83
3.0
3.2
676.67
667.73
u/ml
—
6
11
43
179
2.45
6.83
3.2
3.7
3.90
3.99
e9/l
0.11
43
179
44
187
2.40
6.69
3.4
3.9
57.09
57.18
%
0.02
44
187
50
226
2.26
6.62
1.5
1.7
—
—
—
0
0
254
1849
1.47
6.59
2.9
3.0
2.47
2.45
mmol/l
0.91
229
1636
42
176
2.44
6.59
1.1
1.2
—
—
—
0
0
40
164
2.49
6.57
1.5
1.7
—
—
—
0
0
310
2364
1.42
6.24
3.4
2.3
—
—
—
0
0
38
156
2.48
6.24
1.3
1.1
—
—
—
0
0
56
273
2.10
6.17
1.5
1.3
—
—
—
0
0
946
8643
1.44
6.17
28.6
16.5
14.83
14.88
%
0.10
937
8483
159
1068
1.56
6.01
7.4
7.9
5.08
5.11
kpa
0.17
154
1024
159
1068
1.56
6.01
7.4
7.9
12.49
12.25
kpa
0.26
153
1025
97
575
1.75
5.97
1.8
1.7
—
—
—
0
0
47
217
2.21
5.94
1.4
1.9
1252.17
746.66
e6/l
0.15
40
172
47
217
2.21
5.94
1.4
1.8
3.43
13.33
e6/l
1.13
37
169
159
1074
1.55
5.86
7.4
7.8
1.47
1.17
mmol/l
0.40
130
868
383
3062
1.37
5.74
3.7
3.2
7.04
7.34
mmol/l
0.56
332
2592
28
103
2.76
5.72
1.3
1.4
—
—
—
0
0
66
352
1.93
5.70
2.4
1.8
—
—
—
0
0
18
51
3.57
5.61
1.3
2.2
—
—
—
0
0
18
51
3.57
5.61
1.3
2.2
—
—
—
0
0
47
223
2.15
5.58
1.5
1.7
—
—
—
0
0
76
430
1.82
5.48
1.4
1.5
24.60
27.61
iu/l
0.32
62
363
36
154
2.38
5.44
1.4
1.2
1.50
4.10
u/ml
—
10
39
999
9278
1.44
5.44
20.7
12.6
81.55
81.13
ml/min/173m2
0.24
848
7594
16
34
4.75
5.31
1.7
1.4
9.88
8.69
ug/l
0.27
16
34
46
222
2.11
5.24
1.4
1.5
3.75
3.77
mmol/l
0.05
41
208
159
1106
1.50
5.11
1.6
1.7
1.42
1.46
%
0.24
137
975
94
579
1.68
5.06
2.4
3.3
4.32
4.52
pmol/l
0.97
83
508
49
246
2.03
5.05
1.4
1.5
9.67
10.07
u/l
0.07
40
192
51
260
2.00
5.04
1.7
1.6
—
—
—
0
0
17
50
3.43
5.04
1.2
1.2
—
—
—
0
0
21
72
2.95
4.89
1.1
1.0
—
—
—
0
0
35
156
2.28
4.86
1.4
1.2
3.20
6.68
u/ml
0.67
15
65
43
213
2.06
4.61
1.4
1.4
—
—
—
0
0
16
48
3.36
4.61
1.1
1.2
1.11
1.07
ratio
—
7
18
37
176
2.14
4.42
1.4
1.7
—
—
—
0
0
23
88
2.64
4.41
2.0
1.1
—
—
—
0
0
13
28
4.68
4.37
1.2
1.1
0.31
0.29
g/l
—
8
21
28
119
2.39
4.34
1.3
1.2
—
—
—
0
0
7
6
11.72
4.28
3.4
1.2
—
—
—
0
0
21
78
2.72
4.26
1.1
1.1
25.06
41.40
mg/l
1.63
16
62
26
108
2.44
4.24
1.6
1.8
—
—
—
0
0
20
73
2.77
4.19
1.7
1.7
—
—
—
0
0
52
286
1.85
4.16
1.3
1.2
—
—
—
0
0
53
294
1.84
4.13
3.3
3.5
31.11
44.39
mg/l
0.57
43
238
53
294
1.84
4.13
3.3
3.5
90.98
71.04
mg/l
0.17
44
237
13
30
4.37
4.13
1.4
1.1
—
—
—
0
0
142
1009
1.46
4.12
3.6
4.2
15.28
27.96
ug/l
0.40
119
824
30
135
2.25
4.11
1.4
1.5
—
—
—
0
0
52
288
1.84
4.08
1.3
1.3
247.35
233.30
miu/ml
0.07
16
137
37
182
2.07
4.08
1.8
1.2
269.00
261.11
u/ml
0.05
20
110
54
303
1.82
4.07
1.8
2.0
113.44
2419.58
u/l
—
9
118
1011
9533
1.37
3.97
5.0
4.5
5.97
5.92
mmol/l
0.40
945
8677
1143
11034
1.67
3.96
33.8
20.2
253.97
253.05
e9/l
0.18
1129
10750
319
2604
1.31
3.92
6.1
3.9
0.00
0.01
estimate
1.28
111
883
1143
11038
1.66
3.90
33.8
20.2
6.86
6.68
e9/l
1.27
1129
10728
1143
11038
1.66
3.90
33.8
20.2
4.44
4.48
e12/l
1.52
1130
10726
1142
11027
1.65
3.89
34.0
20.3
39.54
39.90
%
1.08
1062
10303
29
132
2.23
3.88
1.6
1.6
—
—
—
0
0
1143
11040
1.66
3.87
34.2
20.3
133.42
134.64
g/l
2.08
1137
10876
18
65
2.80
3.86
1.6
1.2
—
—
—
0
0
83
533
1.60
3.85
1.3
1.3
—
—
—
0
0
14
44
3.21
3.78
1.2
2.2
22.46
208.31
ug/l
0.48
14
37
31
147
2.14
3.77
1.4
1.5
—
—
—
0
0
18
66
2.75
3.76
1.6
1.2
—
—
—
0
0
19
72
2.67
3.74
1.6
1.3
—
—
—
0
0
1041
9883
1.39
3.74
5.4
4.8
2.73
2.78
mmol/l
1.08
980
9115
28
128
2.22
3.72
1.4
1.5
—
—
—
0
0
957
8974
1.32
3.71
6.4
5.6
39.66
39.75
mmol/mol
0.10
902
8304
15
50
3.03
3.69
1.6
1.5
—
—
—
0
0
56
328
1.74
3.68
2.8
2.2
464.45
416.60
ug/l
0.06
51
305
43
233
1.88
3.64
1.5
1.7
37507.41
14769.63
e6/l
0.44
27
171
24
104
2.33
3.61
2.7
2.4
—
—
—
0
0
15
51
2.97
3.58
1.6
1.5
—
—
—
0
0
34
171
2.02
3.56
1.4
1.5
—
—
—
0
0
1018
9647
1.35
3.56
4.8
4.3
1.46
1.49
mmol/l
1.45
961
8900
87
577
1.55
3.53
1.6
1.5
—
—
—
0
0
32
158
2.05
3.52
1.3
1.6
—
—
—
0
0
32
158
2.05
3.52
1.3
1.6
—
—
—
0
0
6
6
10.04
3.50
3.7
5.5
—
—
—
0
0
20
81
2.49
3.47
1.3
1.5
—
—
—
0
0
20
81
2.49
3.47
1.3
1.5
—
—
—
0
0
20
81
2.49
3.47
1.3
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
52
2.91
3.47
1.1
1.2
—
—
—
0
0
114
805
1.46
3.44
4.4
3.8
83.68
82.02
ng/l
0.08
99
708
338
2823
1.27
3.42
3.5
3.3
438.30
351.58
mg/l
0.12
220
1786
13
42
3.12
3.37
1.1
1.0
—
—
—
0
0
9
18
5.03
3.37
1.3
1.3
—
—
—
0
0
37
197
1.91
3.32
1.7
1.2
—
—
—
0
0
1021
9705
1.34
3.29
4.9
4.3
4.61
4.70
mmol/l
2.37
967
9002
354
2987
1.26
3.27
3.9
3.8
10.30
8.68
mg/mmol
0.29
213
1851
985
9323
1.31
3.22
4.3
3.9
1.30
1.28
mmol/l
0.41
921
8533
17
66
2.60
3.22
2.5
2.7
0.17
0.22
e9/l
0.81
11
59
14
49
2.88
3.19
1.2
1.6
—
—
—
0
0
14
49
2.88
3.19
1.2
1.6
—
—
—
0
0
316
2644
1.26
3.12
1.8
1.7
1.37
1.37
mmol/l
0.01
277
2244
84
572
1.50
3.05
2.3
2.2
12.29
12.57
nmol/l
0.10
78
518
16
62
2.60
3.05
1.1
1.2
—
—
—
0
0
17
68
2.52
3.05
2.5
2.7
447.91
484.59
e6/l
0.12
11
59
83
564
1.51
3.05
2.3
1.9
—
—
—
0
0
5
5
10.03
2.98
1.2
1.0
1.80
1.00
u/field
—
5
5
52
318
1.66
2.98
2.5
4.1
1.31
1.35
mmol/l
0.09
52
311
23
107
2.17
2.98
1.9
1.7
—
—
—
0
0
16
63
2.56
2.96
1.6
1.5
—
—
—
0
0
45
265
1.73
2.96
1.3
1.3
—
—
—
0
0
21
95
2.23
2.91
2.0
1.7
—
—
—
0
0
40
229
1.77
2.90
1.8
1.7
41.43
39.85
nmol/l
0.14
40
219
16
64
2.52
2.88
1.5
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
49
298
1.67
2.87
3.1
2.7
0.33
0.37
u/ml
0.34
23
164
23
109
2.13
2.85
1.0
1.1
—
—
—
0
0
49
299
1.67
2.84
2.4
2.9
—
—
—
0
0
44
261
1.71
2.83
1.2
1.1
—
—
—
0
0
44
261
1.71
2.83
1.4
1.4
—
—
—
0
0
25
123
2.05
2.83
1.8
1.3
—
—
—
0
0
15
60
2.52
2.70
1.1
1.1
1.02
1.11
u/l
—
5
30
22
105
2.12
2.69
1.0
1.1
—
—
—
0
0
10
29
3.47
2.69
1.4
1.1
—
—
—
0
0
9
24
3.77
2.67
1.6
2.1
—
—
—
0
0
11
35
3.16
2.64
1.0
1.5
81.50
83.06
%
—
6
18
11
35
3.16
2.64
1.0
1.1
78.83
85.82
%
—
6
17
35
199
1.78
2.62
2.4
2.1
133.25
129.50
g/l
0.33
24
152
7
15
4.69
2.60
1.9
1.4
—
—
—
0
0
129
983
1.35
2.55
4.3
3.1
—
—
—
0
0
28
150
1.89
2.53
1.2
1.1
—
—
—
0
0
58
381
1.55
2.53
1.8
2.0
2.57
2.08
ug/l
0.15
47
339
134
1031
1.34
2.49
2.4
2.0
—
—
—
0
0
88
634
1.42
2.44
7.9
4.2
1.57
1.90
mmol/l
0.46
62
490
122
929
1.35
2.43
2.2
1.9
—
—
—
0
0
23
117
1.98
2.41
2.5
2.4
9.80
32.17
mg/l
—
5
32
28
153
1.85
2.39
1.1
1.2
—
—
—
0
0
13
52
2.52
2.36
1.3
1.1
—
—
—
0
0
13
52
2.52
2.36
1.3
1.1
—
—
—
0
0
7
17
4.14
2.36
1.0
1.0
—
—
—
0
0
30
169
1.79
2.34
1.9
1.4
119.97
105.72
u/ml
—
6
36
33
192
1.74
2.31
1.7
1.6
—
—
—
0
0
57
382
1.52
2.29
2.2
1.9
—
—
—
0
0
65
448
1.48
2.29
2.0
1.8
—
—
—
0
0
10
34
2.96
2.28
3.8
4.4
—
—
—
0
0
19
92
2.08
2.28
1.9
2.3
—
—
—
0
0
90
664
1.38
2.20
7.8
4.2
5.12
5.15
kpa
0.18
83
641
30
173
1.75
2.18
1.1
1.1
3.85
2.99
u/ml
0.14
18
85
8
24
3.35
2.18
1.1
1.1
—
—
—
0
0
102
772
1.35
2.14
2.2
2.5
7.03
7.37
ug/l
0.08
83
675
52
348
1.52
2.12
2.4
1.8
—
—
—
0
0
8
25
3.21
2.09
1.1
1.7
—
—
—
0
0
14
62
2.27
2.08
1.8
1.3
—
—
—
0
0
23
124
1.87
2.08
2.1
1.6
—
—
—
0
0
26
146
1.80
2.07
1.1
1.1
0.34
1.72
u/ml
1.64
17
71
5
10
5.02
2.07
1.8
1.8
—
—
—
0
0
276
2376
1.21
2.03
5.2
4.8
2.43
2.50
ug/l
0.05
246
2102
37
232
1.61
2.01
1.3
1.8
—
—
—
0
0
10
38
2.64
2.00
1.3
1.7
—
—
—
0
0
10
38
2.64
2.00
1.3
1.7
—
—
—
0
0
33
201
1.66
2.00
1.5
1.4
—
—
—
0
0
16
77
2.09
1.97
1.1
1.0
—
—
—
0
0
23
127
1.83
1.95
1.4
1.4
—
—
—
0
0
23
127
1.83
1.95
1.4
1.4
—
—
—
0
0
23
127
1.83
1.95
1.4
1.4
—
—
—
0
0
10
39
2.58
1.94
1.3
1.7
—
—
—
0
0
23
128
1.81
1.90
1.4
1.4
—
—
—
0
0
23
129
1.80
1.86
1.4
1.4
—
—
—
0
0
23
129
1.80
1.86
1.4
1.4
—
—
—
0
0
11
46
2.40
1.85
4.5
1.5
—
—
—
0
0
6
17
3.54
1.84
1.5
1.1
—
—
—
0
0
244
2096
1.21
1.83
1.8
1.7
459.55
26694117.11
pmol/l
2.06
209
1727
8
29
2.77
1.79
1.3
1.0
—
—
—
0
0
33
208
1.60
1.78
3.2
1.6
—
—
—
0
0
15
74
2.04
1.75
1.5
1.1
—
43.20
—
0
5
222
1901
1.21
1.72
5.2
4.2
21.05
21.01
%
0.01
101
894
5
13
3.86
1.71
1.0
1.5
170.40
95.23
ng/l
—
5
13
11
48
2.30
1.70
1.0
2.1
—
—
—
0
0
10
40
2.51
1.66
3.7
3.2
775.90
700.00
u/ml
—
10
40
6
19
3.17
1.66
1.2
1.1
81.33
96.47
%
—
6
19
22
127
1.75
1.65
1.2
1.2
—
—
—
0
0
30
189
1.60
1.64
3.5
2.3
16.38
16.01
%
0.20
15
97
11
50
2.21
1.57
1.3
1.4
160.77
178.20
pmol/l
0.17
11
50
12
57
2.12
1.55
1.1
1.2
—
—
—
0
0
12
57
2.12
1.55
1.1
1.2
—
—
—
0
0
70
529
1.34
1.54
1.1
1.0
—
—
—
0
0
16
86
1.87
1.50
1.1
2.0
1.50
2.37
u/field
—
10
35
99
791
1.27
1.47
8.7
3.6
1.23
1.23
mmol/l
0.38
91
678
9
38
2.38
1.45
1.6
1.3
—
—
—
0
0
59
439
1.36
1.45
10.6
4.9
24.67
24.92
mmol/l
0.37
54
416
15
80
1.89
1.45
1.1
1.1
—
—
u/ml
—
0
0
17
95
1.80
1.43
1.1
1.1
—
—
—
0
0
9
39
2.32
1.43
1.0
1.4
—
—
—
0
0
9
40
2.26
1.40
1.0
1.1
127.44
146.36
iu/ml
—
9
40
14
75
1.88
1.34
1.1
1.2
0.94
3.34
u/ml
—
9
36
12
61
1.98
1.33
1.2
1.2
—
—
—
0
0
37
258
1.45
1.32
1.4
1.2
—
—
—
0
0
11
55
2.01
1.27
1.2
1.7
0.82
5.83
u/field
0.91
11
40
5
19
2.64
1.21
2.6
2.5
19.02
17.37
umol/l
—
5
19
8
37
2.17
1.21
1.6
1.8
—
—
—
0
0
15
86
1.75
1.19
1.9
2.3
—
—
—
0
0
17
102
1.68
1.16
1.1
1.1
0.09
0.65
u/ml
—
6
30
18
110
1.65
1.15
1.3
1.6
—
—
—
0
0
18
110
1.65
1.15
1.3
1.6
—
—
—
0
0
8
39
2.06
1.15
1.1
1.1
1429.64
1832.03
miu/ml
—
8
39
39
287
1.37
1.08
1.1
1.1
2.53
6.67
u/ml
—
6
34
9
47
1.92
1.02
1.0
1.2
—
—
—
0
0
9
47
1.92
1.02
1.0
1.2
—
—
—
0
0
192
1705
1.15
1.00
1.6
1.4
—
—
—
0
0
7
35
2.01
1.00
3.3
1.7
—
1224630.00
—
0
5
5
23
2.18
0.98
1.0
1.8
1.17
1.24
mmol/l
—
5
23
83
692
1.21
0.92
1.2
1.2
133.67
145.04
iu/ml
0.08
32
270
47
368
1.29
0.89
2.6
3.4
634.04
3823.34
u/ml
0.61
38
318
8
47
1.71
0.80
1.0
1.0
—
—
—
0
0
6
34
1.77
0.76
2.2
1.5
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
5
25
2.00
0.72
1.0
1.4
—
—
—
0
0
29
220
1.33
0.72
6.4
3.0
1.38
1.53
mmol/l
0.71
29
215
21
154
1.37
0.65
1.0
1.1
—
—
—
0
0
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
151
1376
1.11
0.57
3.0
3.0
0.77
0.76
ug/l
0.03
97
910
19
142
1.34
0.54
1.2
1.0
1.97
2.03
u/ml
—
7
62
29
232
1.26
0.52
2.2
2.3
55.77
84.84
ug/min
0.39
15
139
13
92
1.42
0.50
1.2
1.3
25901.63
108384.45
e6/l
—
8
51
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
8
59
1.36
0.41
1.1
1.5
1.53
1.57
g/l
—
8
59
16
123
1.30
0.40
1.6
2.5
33.50
32.67
pg
0.38
16
123
5
34
1.47
0.40
3.0
2.9
—
—
—
0
0
5
34
1.47
0.40
3.0
2.9
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
127
1176
1.09
0.38
7.5
7.0
—
—
—
0
0
16
203
0.79
0.38
1.6
1.5
—
—
—
0
0
16
125
1.28
0.37
1.3
1.1
—
—
—
0
0
9
70
1.29
0.36
1.2
1.5
0.83
1.02
g/l
—
9
70
6
42
1.43
0.35
1.8
2.6
37016.67
37219.17
ug/l
—
6
42
31
362
0.85
0.35
1.5
1.4
—
—
—
0
0
6
45
1.33
0.33
1.2
1.2
—
—
—
0
0
21
253
0.83
0.33
1.3
1.4
66.14
262.92
pmol/l
2.18
21
248
130
1217
1.08
0.32
4.5
4.4
33.36
32.61
%
0.35
97
824
13
101
1.29
0.31
2.5
3.7
—
—
—
0
0
62
562
1.11
0.30
2.9
3.2
45.86
61.48
u/ml
0.32
62
542
77
833
0.92
0.27
1.8
1.7
—
—
—
0
0
13
160
0.81
0.26
2.2
1.6
—
—
—
0
0
16
191
0.84
0.24
1.6
1.4
—
—
—
0
0
16
191
0.84
0.24
1.6
1.4
—
—
—
0
0
16
190
0.84
0.23
1.6
1.4
—
—
—
0
0
16
190
0.84
0.23
1.6
1.4
—
—
—
0
0
32
359
0.89
0.23
1.4
1.5
—
—
—
0
0
15
178
0.84
0.22
1.5
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
9.03
—
0
11
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
19
164
1.16
0.20
1.3
1.1
1.40
174.85
iu/ml
—
5
41
0
14
0.00
0.20
0.0
1.1
—
30.26
—
0
9
82
773
1.07
0.19
4.6
2.5
68.68
66.62
ml/min/173m2
0.18
38
317
29
260
1.12
0.19
1.3
1.7
1.71
4.93
iu/l
—
10
86
7
60
1.17
0.17
1.1
1.2
8.57
11.68
u/l
—
7
53
18
205
0.88
0.17
3.0
3.6
20.84
25.08
mg/l
0.36
12
133
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
34
369
0.92
0.15
1.6
1.8
2.56
4.98
mg/l
0.86
26
283
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
5
45
1.11
0.10
6.6
2.5
58.60
48.06
umol/l
—
5
34
5
46
1.09
0.09
2.8
2.5
—
—
—
0
0
10
87
1.15
0.09
1.4
1.6
—
—
—
0
0
5
48
1.04
0.09
1.6
3.8
—
—
—
0
0
14
127
1.10
0.08
1.0
1.1
—
—
—
0
0
26
249
1.05
0.04
1.2
1.4
—
—
—
0
0
14
134
1.05
0.00
1.3
1.5
—
—
—
0
0
34
334
1.02
0.00
1.5
1.5
—
—
—
0
0
13
133
0.98
0.00
1.0
1.0
1.55
1.51
g/l
0.11
13
120
0
6
0.00
0.00
0.0
1.0
—
38.27
—
0
6
0
6
0.00
0.00
0.0
1.0
—
20.63
—
0
6
0
6
0.00
0.00
0.0
1.0
—
7.65
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
577.00
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
75
0.93
-0.00
1.0
1.1
302.14
289.87
mg/l
—
7
63
5
56
0.89
-0.00
1.8
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_ERYTH_NAS – Other and unspecified erythematous conditions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).